Search

Albert Mark Navarro

Examiner (ID: 439, Phone: (571)272-0861 , Office: P/1645 )

Most Active Art Unit
1645
Art Unit(s)
1645, 1621, 2899, 1817
Total Applications
2079
Issued Applications
1540
Pending Applications
155
Abandoned Applications
410

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17890926 [patent_doc_number] => 11453883 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-27 [patent_title] => Display systems for proteins of interest [patent_app_type] => utility [patent_app_number] => 16/375894 [patent_app_country] => US [patent_app_date] => 2019-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 15754 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16375894 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/375894
Display systems for proteins of interest Apr 4, 2019 Issued
Array ( [id] => 14893975 [patent_doc_number] => 20190290753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-26 [patent_title] => COMPOSITIONS AND METHODS FOR INDUCTION OF TH17 CELLS [patent_app_type] => utility [patent_app_number] => 16/375935 [patent_app_country] => US [patent_app_date] => 2019-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11668 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16375935 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/375935
COMPOSITIONS AND METHODS FOR INDUCTION OF TH17 CELLS Apr 4, 2019 Abandoned
Array ( [id] => 16581475 [patent_doc_number] => 20210015877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-21 [patent_title] => LACTOBACILLUS FERMENTUM FOR TREATING FRUCTOSE-RELATED DISEASES [patent_app_type] => utility [patent_app_number] => 17/040019 [patent_app_country] => US [patent_app_date] => 2019-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5105 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17040019 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/040019
None Mar 11, 2019 Issued
Array ( [id] => 16413304 [patent_doc_number] => 10821166 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-03 [patent_title] => Isolated polypeptide of the toxin A and toxin B proteins of [patent_app_type] => utility [patent_app_number] => 16/295031 [patent_app_country] => US [patent_app_date] => 2019-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 26 [patent_no_of_words] => 30177 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16295031 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/295031
Isolated polypeptide of the toxin A and toxin B proteins of Mar 6, 2019 Issued
Array ( [id] => 16581473 [patent_doc_number] => 20210015875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-21 [patent_title] => NANOVESICLES DERIVED FROM ENHYDROBACTER BACTERIA, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/978562 [patent_app_country] => US [patent_app_date] => 2019-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6890 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16978562 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/978562
Nanovesicles derived from enhydrobacter bacteria, and use thereof Mar 4, 2019 Issued
Array ( [id] => 17648504 [patent_doc_number] => 11351207 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-07 [patent_title] => Use of direct-fed microbials in preventing and/or treating [patent_app_type] => utility [patent_app_number] => 16/977514 [patent_app_country] => US [patent_app_date] => 2019-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10033 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977514 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/977514
Use of direct-fed microbials in preventing and/or treating Mar 3, 2019 Issued
Array ( [id] => 15175437 [patent_doc_number] => 20190358310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-11-28 [patent_title] => METHOD FOR REDUCING SKATOLE AND/OR INDOLE IN ANIMALS [patent_app_type] => utility [patent_app_number] => 16/283946 [patent_app_country] => US [patent_app_date] => 2019-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7291 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16283946 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/283946
Method for reducing skatole and/or indole in animals Feb 24, 2019 Issued
Array ( [id] => 18994944 [patent_doc_number] => 11911764 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-27 [patent_title] => System and method for cell imaging, analysis and measurement [patent_app_type] => utility [patent_app_number] => 16/963233 [patent_app_country] => US [patent_app_date] => 2019-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 8095 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16963233 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/963233
System and method for cell imaging, analysis and measurement Feb 20, 2019 Issued
Array ( [id] => 14406787 [patent_doc_number] => 20190169237 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-06 [patent_title] => MUTANT ADENO-ASSOCIATED VIRUS VIRIONS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/274935 [patent_app_country] => US [patent_app_date] => 2019-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23436 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16274935 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/274935
MUTANT ADENO-ASSOCIATED VIRUS VIRIONS AND METHODS OF USE THEREOF Feb 12, 2019 Abandoned
Array ( [id] => 14682385 [patent_doc_number] => 20190240307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-08 [patent_title] => SYNTHETIC IMMUNOGENS FOR PROPHYLAXIS OR TREATMENT OF TUBERCULOSIS [patent_app_type] => utility [patent_app_number] => 16/272203 [patent_app_country] => US [patent_app_date] => 2019-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22860 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16272203 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/272203
Synthetic immunogens for prophylaxis or treatment of tuberculosis Feb 10, 2019 Issued
Array ( [id] => 16511571 [patent_doc_number] => 20200390828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-17 [patent_title] => LIPOPOLYSACCHARIDE-REGULATED ENTERIC BACTERIA AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/968376 [patent_app_country] => US [patent_app_date] => 2019-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18417 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16968376 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/968376
Lipopolysaccharide-regulated enteric bacteria and use thereof Feb 7, 2019 Issued
Array ( [id] => 14338915 [patent_doc_number] => 20190151430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-23 [patent_title] => ADJUVANTING MENINGOCOCCAL FACTOR H BINDING PROTEIN [patent_app_type] => utility [patent_app_number] => 16/269370 [patent_app_country] => US [patent_app_date] => 2019-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16781 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16269370 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/269370
Adjuvanting meningococcal factor H binding protein Feb 5, 2019 Issued
Array ( [id] => 16673103 [patent_doc_number] => 20210061866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-04 [patent_title] => SEA LICE ANTIGENS AND VACCINES [patent_app_type] => utility [patent_app_number] => 16/963645 [patent_app_country] => US [patent_app_date] => 2019-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10291 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16963645 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/963645
SEA LICE ANTIGENS AND VACCINES Jan 24, 2019 Abandoned
Array ( [id] => 14273781 [patent_doc_number] => 20190134175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-09 [patent_title] => EHRLICHIAL INVASIN FOR IMMUNIZTION, DIAGNOSIS, AND CELL DELIVERY [patent_app_type] => utility [patent_app_number] => 16/245904 [patent_app_country] => US [patent_app_date] => 2019-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18131 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16245904 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/245904
None Jan 10, 2019 Issued
Array ( [id] => 15191287 [patent_doc_number] => 10493114 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-03 [patent_title] => Lactobacillus-based [patent_app_type] => utility [patent_app_number] => 16/236096 [patent_app_country] => US [patent_app_date] => 2018-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 25100 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16236096 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/236096
Lactobacillus-based Dec 27, 2018 Issued
Array ( [id] => 17655440 [patent_doc_number] => 20220175905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => MONOVALENT VACCINE FORMULATION AND A METHOD FOR PREPARATION THEREOF [patent_app_type] => utility [patent_app_number] => 16/960865 [patent_app_country] => US [patent_app_date] => 2018-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3311 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16960865 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/960865
Monovalent vaccine formulation and a method for preparation thereof Dec 25, 2018 Issued
Array ( [id] => 16485367 [patent_doc_number] => 20200378970 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-03 [patent_title] => COMPANION DIAGNOSTIC FOR HTRA1 RNA ANTAGONISTS [patent_app_type] => utility [patent_app_number] => 16/766497 [patent_app_country] => US [patent_app_date] => 2018-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20872 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16766497 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/766497
COMPANION DIAGNOSTIC FOR HTRA1 RNA ANTAGONISTS Dec 18, 2018 Abandoned
Array ( [id] => 16484019 [patent_doc_number] => 20200377620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-03 [patent_title] => CLOSTRIDIUM PERFRINGENS SURFACE GLYCANS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/770275 [patent_app_country] => US [patent_app_date] => 2018-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10952 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770275 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/770275
CLOSTRIDIUM PERFRINGENS SURFACE GLYCANS AND USES THEREOF Dec 18, 2018 Abandoned
Array ( [id] => 16962903 [patent_doc_number] => 20210214402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => IMMUNOGENIC COMPOSITION [patent_app_type] => utility [patent_app_number] => 16/954306 [patent_app_country] => US [patent_app_date] => 2018-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28605 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16954306 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/954306
Immunogenic composition Dec 18, 2018 Issued
Array ( [id] => 16688673 [patent_doc_number] => 20210071149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => AAV-MEDIATED DELIVERY OF THERAPEUTIC ANTIBODIES TO THE INNER EAR [patent_app_type] => utility [patent_app_number] => 16/955715 [patent_app_country] => US [patent_app_date] => 2018-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24820 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -102 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16955715 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/955715
AAV-MEDIATED DELIVERY OF THERAPEUTIC ANTIBODIES TO THE INNER EAR Dec 18, 2018 Abandoned
Menu